 |
|
Treatment of experimental vitreous hemorrhage with tissue plasminogen activator.
Woog Ki Min, Yong Baik Kim, Kyung Moo Lee
Korean J Ophthalmol. 1990;4(1):12-15. Published online 1990 Jun 30 DOI: https://doi.org/10.3341/kjo.1990.4.1.12
|
|
Citations to this article as recorded by
 INTRAVITREAL TISSUE PLASMINOGEN ACTIVATOR, PERFLUOROPROPANE (C3F8), AND RANIBIZUMAB OR PHOTODYNAMIC THERAPY FOR SUBMACULAR HEMORRHAGE SECONDARY TO WET AGE-RELATED MACULAR DEGENERATION
Evangelia Papavasileiou, David H. W. Steel, Efstathios Liazos, Dominic McHugh, Timothy L. Jackson
Retina.2013; 33(4): 846. CrossRef Tissue Plasminogen Activator in the Treatment of Vitreoretinal Diseases
Motohiro Kamei, Marc Estafanous, Hilel Lewis
Seminars in Ophthalmology.2000; 15(1): 44. CrossRef Vitreous hemorrhage
Christoph W. Spraul, Hans E. Grossniklaus
Survey of Ophthalmology.1997; 42(1): 3. CrossRef
|